Medicare Durable Medical
Equipment, Prosthetics, Orthotics, and Supplies (DMEPOS)
Competitive Bidding Program – Contracting Forms (CMS-10744)
New
collection (Request for a new OMB Control Number)
No
Regular
11/05/2020
Requested
Previously Approved
36 Months From Approved
271,597
0
32,121
0
0
0
The Medicare Durable Medical
Equipment, Prosthetics, Orthotics, and Supplies (DMEPOS)
Competitive Bidding Program was established by the Medicare
Prescription Drug, Improvement, and Modernization Act of 2003
(“Medicare Modernization Act” or “MMA”). Section 302 of the MMA
amended Section 1847 of the Social Security Act (the Act) to
establish the competitive acquisition program and define program
requirements. Under the MMA, the DMEPOS Competitive Bidding Program
was to be phased in so that competition under the program would
first occur in 10 areas in 2007. The Centers for Medicare &
Medicaid Services (CMS) completed the rulemaking process for the
competitive acquisition of DMEPOS items and services in 42 CFR
Parts 411 and 414 published in the Federal Register Volume 72 on
April 10, 2007. CMS conducted the Round 1 competition in 10 areas
and for 10 DMEPOS product categories, and implemented the program
on July 1, 2008. The Medicare Improvements for Patients and
Providers Act of 2008 (MIPPA), enacted on July 15, 2008, made
limited changes to the Competitive Bidding Program, including
termination of existing contracts that were in effect and a
requirement to re-bid Round 1. As required by MIPPA, CMS conducted
the competition for the Round 1 Rebid in 2009. The Round 1 Rebid
contracts and prices became effective on January 1, 2011. The
Affordable Care Act (ACA), enacted on March 23, 2010, expanded the
Round 2 competition by adding an additional 21 metropolitan
statistical areas (MSAs), bringing the total MSAs for Round 2 to
91. The competition for Round 2 began in December 2011. CMS also
began a competition for National Mail Order (NMO) of diabetes
testing supplies at the same time as Round 2. The Round 2 and NMO
contracts and prices were implemented on July 1, 2013. The MMA
requires the Secretary to recompete contracts not less often than
once every three years. The Round 1 Rebid contract period for all
product categories except mail-order diabetes testing supplies
expired on December 31, 2013. (Round 1 Rebid contracts for
mail-order diabetes testing supplies ended on December 31, 2012.)
The competition for the Round 1 Recompete began in August of 2012
and contracts and prices became effective on January 1, 2014. The
Round 1 Recompete contract period expires on December 31, 2016.
Round 1 2017 contracts will become effective on January 1, 2017
through December 31, 2018. Round 2 and NMO contracts and prices
expired on June 30, 2016. Round 2 Recompete and the NMO Recompete
contracts became effective on July 1, 2016, and expired on December
31, 2018. CMS will be implementing a consolidated round of
competition to include all Round 1 2017 and Round 2 Recompete
competitive bidding areas, referred to as Round 2021. Round 2021
will not include NMO, which will be competed again in future rounds
of the program.
PL:
Pub.L. 110 - 275 154 Name of Law: Delay in and reform of
Medicare DMEPOS competitive acquisition program.
PL:
Pub.L. 108 - 173 302 Name of Law: Payment for durable medical
equipment; competitive acquisition of certain items and
services.
PL:
Pub.L. 111 - 148 6410 Name of Law: Adjustments to the Medicare
durable medical equipment, prosthetics, orthotics, and supplies
competit
On behalf of this Federal agency, I certify that
the collection of information encompassed by this request complies
with 5 CFR 1320.9 and the related provisions of 5 CFR
1320.8(b)(3).
The following is a summary of the topics, regarding
the proposed collection of information, that the certification
covers:
(i) Why the information is being collected;
(ii) Use of information;
(iii) Burden estimate;
(iv) Nature of response (voluntary, required for a
benefit, or mandatory);
(v) Nature and extent of confidentiality; and
(vi) Need to display currently valid OMB control
number;
If you are unable to certify compliance with any of
these provisions, identify the item by leaving the box unchecked
and explain the reason in the Supporting Statement.